Oxford Vaccine Approved
December 30, 2020
196,354
7,512
3,095
5.40%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr John Campbell Episodes Around December 30, 2020
See what was published immediately before and after this episode.
24:43Now PlayingOxford Vaccine Approved
YouTube Description
as posted by the channelIn the next few months,
UK
Cases, + 53,135
Deaths, + 414
ChAdOx1
Three weeks for good level of immunity
After this people were not hospitalised
One dose can prevent serious disease
Day 22 to 3 months = 70% to 80%
Three billion doses of the vaccine
30 supply agreements and partner networks
Medicines and Healthcare products Regulatory Agency (MHRA)
Has approved two full doses of the Oxford-AstraZeneca vaccine
Not enough clear data to approve the half-dose, full-dose idea
First doses, Monday, 4th January
Pfizer
21 days is not the minimum gap, get more people protected quicker
Doctors can decide to give to pregnant and breast feeding women
People with allergies can also be considered
Joint Committee on Vaccination and Immunisation
Give as many people as possible their first dose of vaccine
Give as many vulnerable people some protection from Covid-19
Second dose, 4 to 12 weeks
Second dose, longer term protection.
Oxford already working on flexibility
Oxford/AstraZeneca Vaccine
MHRA, Medicines and Healthcare Products Regulatory Agency
Fast-track rolling review of the vaccine since November
Enters stage 4 on approval
Pre-orders
EU, 400 million doses
UK, 100 million
US, 300 million
China, 200 million
Japan, 120 million
Brazil, 100 million
Mexico, 77 million
Chile, 14,4 million
Indonesia, 100 million
Australia, 33.6 million
Egypt 30 million
Argentina 32 million
Ecuador 5 million
Canada 20 million
Argentina and Mexico to produce for Latin America
Vaccines alliance for poorer countries, 300 million
COVAX, 170 million
Three billion doses in 2021
Cost
£2
Transport / storage
Fridge temperatures
Lasts six months when refrigerated at 38–46°F (2–8°C)
Efficacy
Pascal Soriot, winning formula
62% 70% 90% 100%
Strong response in older adults
Manufacturing
Keele, UK
Belgium
India, Serum Institute, 1 billion doses
Melbourne, Australia
Thailand, South East Asia
Netherlands and Germany
Across Europe
Shenzhen, China
US
Albuquerque, New Mexico
Maryland
Russia
Mexico
UK, 100 million
Four million ready to go
Fifteen million ready to put into vials
Mass rollout starts 4th January
One million people per week
Mass rollout
Important that no screening is required
Reactogenicity does not appear to be affected by the presences of antibodies to coronavirus.
US
Mr. Biden, 100 million shots in first 100 days
Published evidence base
AZ press release
Oxford vaccine, home site
The Oxford Coronavirus Site
The Jenner Institute
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.